

Founded in 2016, Docturnal operates in Health Tech industry. Initially focusing on leveraging spectroscopy and artificial intelligence to detect conditions such as tuberculosis, the company has expand...
Funding stage:
Seed
Last funding:
24/09/2018
Total funding:
$14.74K+
Revenue:
Investors
Employee count:
4
Last 90d
4
Last 90d
Docturnal: Cap Table Highlights
A snapshot of cap table and shareholder metrics
- Total Shareholders21
- Latest Filing Date30 March 2021
- Funding Events11
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Docturnal
As of 31 March 2021, Docturnal's equity is held by 20 shareholders, with the top three being Rahul Pathri, Vaishnavi Reddy, and Axilor Technology Fund I.
Rahul Pathri holds the largest stake in Docturnal at 65.7% as of 31 March 2021.
As of 31 March 2021, founders collectively hold 71.6% equity in Docturnal.
As of 31 March 2021, investors collectively hold 17.1% equity in Docturnal.
Docturnal's ESOP pool stands at 10.5% of total equity as of 31 March 2021.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links